Viewing Study NCT04802356


Ignite Creation Date: 2025-12-24 @ 11:32 PM
Ignite Modification Date: 2025-12-25 @ 9:20 PM
Study NCT ID: NCT04802356
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-17
First Post: 2021-03-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Belantamab Mafodotin in Newly Diagnosed Transplant Eligible Multiple Myeloma Patients
Sponsor: PETHEMA Foundation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module